Our pipeline

Diversified candidates with great potential

Our platform technologies can be used to discover and modify various biologics and applied to a wide range of disease areas. If you are interested in discussing partnerships using our platforms or on the below assets, please contact us.

Candidates Indication Phase Technology
Discovery Candidate ready Preclinical Phase 1 Phase 2 Phase 3
GT-02037 Acromegaly Endocrinology rare disease now Glycosylation
GT-15019 Multiple sclerosis Autoimmune rare disease now Glycosylation
GT-01123 Type 2 diabetes Endocrinology now Glycosylation
TBA1 Diabetes mellitus Endocrinology now Glycosylation
TBA2 COVID-19 Infection now Scaffold peptide